Jan. 22, 2021 14:00 UTC
Clarity Mobile Ventures to Bring COVID-19 and Antigen Testing to Chicago
Clarity Mobile Ventures to Bring COVID-19 and Antigen Testing to Chicago Jan. 22, 2021 14:00 UTC Clarity Mobile Ventures to Bring COVID-19 and Antigen Testing to Chicago – Capacity for up to 10,000 Tests Per Day – CHICAGO--(BUSINESS WIRE)-- SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading designer, innovator and fabricator of container-based structures, announced today that its Clarity Mobile Ventures (“CMV”) joint venture partnership with Clarity Lab Solutions is teaming up with National Pain Centers, a medical practice with multiple locations in the Chicago area, to bring rapid COVID-19 testing to Chicago area travelers, airport employees, a
Jan. 22, 2021 14:00 UTC
Cloudflare Announces Project Fair Shot, A Digital Waiting Room for Fair and Efficient COVID-19 Vaccine Distribution
Cloudflare Announces Project Fair Shot, A Digital Waiting Room for Fair and Efficient COVID-19 Vaccine Distribution Jan. 22, 2021 14:00 UTC Cloudflare Announces Project Fair Shot, A Digital Waiting Room for Fair and Efficient COVID-19 Vaccine Distribution Project Fair Shot to offer free service for any government agency, hospital, pharmacy, or organization facilitating the distribution of COVID-19 vaccines SAN FRANCISCO--(BUSINESS WIRE)-- Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today announced Project Fair Shot to offer a free and fair way for vaccine distributors around the world to use digital queues
Jan. 22, 2021 13:00 UTC
Office Properties Income Trust Fourth Quarter 2020 Conference Call Scheduled for Friday, February 19th
Office Properties Income Trust Fourth Quarter 2020 Conference Call Scheduled for Friday, February 19th Jan. 22, 2021 13:00 UTC Office Properties Income Trust Fourth Quarter 2020 Conference Call Scheduled for Friday, February 19th NEWTON, Mass.--(BUSINESS WIRE)-- Office Properties Income Trust (Nasdaq: OPI) today announced that it will issue a press release containing its fourth quarter 2020 financial results after the Nasdaq closes on Thursday, February 18, 2021. On Friday, February 19, 2021 at 10:00 a.m. Eastern Time, President and Chief Operating Officer Christopher Bilotto and Chief Financial Officer Matthew Brown will host a conference call to discuss these results. The conf
Jan. 22, 2021 12:05 UTC
HempFusion to Ring Today’s Opening Bell of the Toronto Stock Exchange
HempFusion to Ring Today’s Opening Bell of the Toronto Stock Exchange Jan. 22, 2021 12:05 UTC HempFusion to Ring Today’s Opening Bell of the Toronto Stock Exchange DENVER--(BUSINESS WIRE)-- HempFusion Wellness Inc. (TSX:CBD.U) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, will celebrate the Company’s listing on the Toronto Stock Exchange (“TSX”) by virtually ringing the TSX opening bell at 9:30 a.m. ET today. As previously announced, HempFusion completed its $17,000,000 initial public offering and commenced trading on the TSX on January 6, 2021. This press release features mul
Jan. 22, 2021 12:00 UTC
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19
Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19 Jan. 22, 2021 12:00 UTC Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19 The Cooperative Research and Development Agreement (CRADA) with the Department of Defense (DoD) and the Biomedical Advanced Research and Development Authority (BARDA) supports the development of lenzilumab as a potential treatment for patients with COVID-19 BURLINGAME, Calif.--(BUSINESS WIRE)-- Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing a
Jan. 22, 2021 13:00 UTC
Revance Issues Inaugural Environmental, Social and Governance (ESG) Report
Revance Issues Inaugural Environmental, Social and Governance (ESG) Report Jan. 22, 2021 13:00 UTC Revance Issues Inaugural Environmental, Social and Governance (ESG) Report NASHVILLE, Tenn.--(BUSINESS WIRE)-- Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the release of its inaugural ESG Report, which details the company’s commitments and efforts to build strong corporate governance, and operate sustainably and responsibly, including its response to the COVID-19 pandemic and prevailing social issues in 2020. The report was guided by the Sustainability Accounting Standards Board (SASB)

Execution time: 0.3375 seconds
Layout: desktop